I
450.06
-3.43 (-0.76%)
| Previous Close | 453.49 |
| Open | 454.32 |
| Volume | 2,390,980 |
| Avg. Volume (3M) | 1,906,085 |
| Market Cap | 159,394,529,280 |
| Price / Earnings (TTM) | 54.62 |
| Price / Earnings (Forward) | 43.67 |
| Price / Sales | 15.43 |
| Price / Book | 9.16 |
| 52 Weeks Range | |
| Earnings Date | 21 Jul 2026 |
| Profit Margin | 28.41% |
| Operating Margin (TTM) | 25.66% |
| Diluted EPS (TTM) | 6.81 |
| Quarterly Revenue Growth (YOY) | 19.20% |
| Quarterly Earnings Growth (YOY) | 28.20% |
| Total Debt/Equity (MRQ) | 0.88% |
| Current Ratio (MRQ) | 4.98 |
| Operating Cash Flow (TTM) | 2.73 B |
| Levered Free Cash Flow (TTM) | 1.66 B |
| Return on Assets (TTM) | 8.84% |
| Return on Equity (TTM) | 15.96% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Bearish | |
| Stock | Intuitive Surgical, Inc. | Bullish | Bearish |
AIStockmoo Score
1.5
| Analyst Consensus | 5.0 |
| Insider Activity | -2.5 |
| Price Volatility | 4.5 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | 1.50 |
|
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed more than 9,500 da Vinci systems in hospitals worldwide, with more than 5,500 installations in the US and a growing number in emerging markets. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Large Growth |
| % Held by Insiders | 0.52% |
| % Held by Institutions | 89.06% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 590.00 (Citigroup, 31.09%) | Buy |
| Median | 580.00 (28.87%) | |
| Low | 570.00 (UBS, 26.65%) | Hold |
| Average | 580.00 (28.87%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 493.45 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 11 Mar 2026 | 590.00 (31.09%) | Buy | 492.87 |
| UBS | 24 Feb 2026 | 570.00 (26.65%) | Hold | 494.02 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| BARRATT CRAIG H | - | - | 0 | 0 |
| BEERY JOSEPH C | - | - | 0 | 0 |
| CHEW LEWIS | - | - | 0 | 0 |
| JOHNSON AMAL M | - | - | 0 | 0 |
| KOLLI SREELAKSHMI | - | - | 0 | 0 |
| LADD AMY L | - | 453.83 | -119 | -54,006 |
| LEONARD KEITH R | - | - | 0 | 0 |
| NACHTSHEIM JAMI K | - | - | 0 | 0 |
| REED MONICA P | - | - | 0 | 0 |
| Aggregate Net Quantity | -119 | |||
| Aggregate Net Value ($) | -54,006 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 453.83 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| BARRATT CRAIG H | Director | 30 Apr 2026 | Option execute | 750 | - | - |
| BEERY JOSEPH C | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| CHEW LEWIS | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| JOHNSON AMAL M | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| KOLLI SREELAKSHMI | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| LADD AMY L | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| LEONARD KEITH R | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| NACHTSHEIM JAMI K | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| REED MONICA P | Director | 30 Apr 2026 | Option execute | 531 | - | - |
| LADD AMY L | Director | 29 Apr 2026 | Automatic sell (-) | 119 | 453.83 | 54,006 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |